BIBLIOGRAFÍA

1.Castoriadis, C. (1997). El Avance de la Insignificancia. Buenos Aires: EUDEBA, p.. 256.

2. Rodríguez-Arias, D. (2014). La bioética global. Una ampliación de la agenda para la bioética. Dilemata, 6 (15): 233-241. p. 236.

3. Savulescu J. (2015) Bioethics: why philosophy is essential for progress. Journal of Medical Ethics, 41:28–33. P. 3-5.

4. Hedgecoe, A.M. (2004). Critical bioethics: beyond the social science critique of applied ethics. Bioethics 18(2): 120-143, p.125.

5. Dawson A. (2010). The future of bioethics: three dogmas and a cup of hemlock. Bioethics 24 (5): 218-225.

6. Macklin, R. (2010). The death of bioethics (as we once knew it). Bioethics 24(5): 211-217.

7. Maldonado, C.E. (2012). Crisis of bioethics and bioethics in the midst of crises. Revista Latinoamericana de Bioética 12 (1): 112-123.

8. Margaret E Kruk, M.E., Ataguba, J.E., Akweongo, P. (2020). The universal health coverage ambition faces a critical test. The Lancet DOI:https:// doi.org/10.1016/S0140-6736(20)31795-5. Accesado Septiembre 03, 2020.

9. Varsi Respigliosi, Rosenvald N., Torres Maldonado, M.A. (2020). La pandemia de la covid-19, la fuerza mayor y la alteración de las circunstancias en materia contractual. Acta Bioethica 26(1): 29-36, p. 30.

10. Marin , C. (2020). Réapprendre la maladie. Esprit (Mayo): 55-60,p-55.

11. Fritz, Z. (2020). Ethical road map through the covid-19 pandemic. British Medical Journal. DOI 10.1136/bmj. m2033.

12. Häyry, M. (2020). The COVID-19 Pandemic: Healthcare Crisis Leadership as Ethics Communication. Cambridge Quarterly of Healthcare Ethics doi: 10.1017/S0963180120000444.

13. Gourevitch, V. (2000). Rousseau on Providence. The Review of Metaphysics, 53(3), 565-611, p. 592. Accesado August 10, 2020.

14. Potter, V.R. (1962). Bridge to the Future: The Concept of Human Progress. Journal of Land Economics 38: 1-8.

15. Holland, S. (2007): Public health ethics. Cambridge: Polity Press.

16. Huxtable, R. (2020). COVID-19: where is the national ethical guidance. BMCMedical. Ethics https://covid19.elsevierpure.com/es/publications/ covid-19-where-is-the-nationalethical-guidance 21. Accesado Julio 15, 2020.

17. Fritz, Z., Huxtable, R., Paton, A., Slowther, A., Wilkinson, D. (2020). Ethical road map through the covid-19 pandmemic. British Medical Journal https://doi.org/10.1136/bmj.m2033 (Published 21 May 2020) Accesado Julio 15, 2020.

18. Blumenthal-Barby, J. et al. (2020). Pandemic medical ethics. Journal of Medical Ethics. 46 (6): 353-354.

19. Ienca, M., Andorno, R. (2017). Towards new human rights in the age of neuroscience and neurotechnology. Life Sciences, Society and Policy. DOI 10.1186/s40504-017-0050-1. Accesado Julio 20, 2020.

20. Dawson, A., Emanuel, E.J., Parker, M., Smith, M.J., Voo, T. C. (2020). Key Ethical Concepts and Their Application to COVID-19 Research. Public Health Ethics. DOI 10.1093/phe/phaa017, p. 1.

21. Bourdieu, P., Wacquant, L. .(2005). Una invitación a la sociología reflexiva. Buenos Aires: Siglo Veintiuno Editores Argentina.

22. Rogers, W. (2019). Bioethics and activism: A natural fit? Bioethics DOI: 10.1111/bioe.12558m p. 883.

23. Epstein, M. (2010). How will the ecnomic downturn affect academic bioethics? Bioethics 24(5): 226-233.

24. Bauman, Z. y Donskis, L. (2019), Maldad líquida. Buenos Aires: Paidós, p.49.

25. Petersen y Lupton (2000). The new public health. Londo: Sage Publications, op. cit., p.167.

26. Petersen, A., Lupton, D. (2000). Op. cit., p. 23.

27. James, J.E. (2014). Personalised medicine, disease prevention, and the inverse care law: more harm than benefits? European Journal of Epidemiology 29: 383-390. 29. Furedi, F. (2018). How Fear Works. London: Bloomsberry Continuum, (p. 151 en versión Kindle).

30. Furedi, F. (1997). Culture o f Fear. London: Cassell.

31. Bauman, Z., Donskis, (2019). Op. cit., p. 60.

32. Dela Ravanal, M., Aurenque, D.S. (2018). Medicalización, prevención y cuerpos sanos: la actualidad de los aportes de Illich y Foucault. Tópicos (México). https://doi.org/10.21555/top.v0i55.914. Accesado Agosto 17, 2020.

33. Jonas H. (1995). El principio responsabilidad. Barcelona: Herder Editorial.

34. Bauman, Z. Donskis, L. (2017) Moral Blindness. Cambridge: Polity Press, p. 107.

35. D’Agostino, F.D. (20022). Bioética y derecho. Acta Bioethica VIII (2): 177-182, p. 181.

36. Carleton, R.N. (2016). Fear of the Unkown: One Fear to Rule them All? Journal of anxiety disorders, 41:5-21.

37. Tudor, A. (2003). A (macro) sociology of fear. Sociological Review 51 (2): 238-256, p.251.

38. Hottois, G. (2001). Bioéthique. En Hottois, G., Missa J-N. Eds). Nouvelle encyclopédie de bioéthque. Bruxelles: De Boeck Université,124-131, p. 124.

39. Rojs, A.O., Labra, L. (2014). ¿Ética, bioética o ética médica? Revista chilena de enfermedades respiratorias 30(2): 91-94, p. 92.

40. González, J. (2002). Ética y Bioética. Isegoría 27: 41-53, p. 41.

41. Potter, V.R. (1971). Bioethics. Bridge to the Future. Englewood Cliffs: Prentice-Hall, p.

42. Elliot, C. (2001). Throwing a Bone to the Watchdog. The Hastings Center Report 31 (2):9-12 ).

43. Schaffer J-M. (2009). El fin de la excepción humana. Buenos Aires: Fondo de cultura Económica de Argentina, p. 45.

44. Ibid., p. 26.

45. Levine, R.J. (1979) Clarifying the Concepts of Research Ethics. The Hastings Center Report 9(3): 21-26.

46 Maliandi, R. (2004). Ética: conceptos y problemas. Buenos Aires:Editorial Biblos, p. 70.

47. Chow-White, P.A., MacAulay, M., Charters, A., Chow, P. (2015). From bench to the bedside in the big data age: ethics and practices of consent and privacy for clinical genomics and personalized medicine. Ethics and Information Technology 17: 189-200, p.187.

48. Coekelbergh, M. (2010). Healthcare, Capabilities, and AI Assistive Technologies. Ethical Theory and Moral Practice 13: 181-190,p. 183.

49. Bostrom N., Yukowsky, E. (2011). The Ethics of Artificial Intelligence. https://www.nickbostrom.com/ethics/artificial-intelligence.pdf. p. 18. Accesado Agosto 26, 2020.

50. Galas, D.J., Hood, L. (2009). Systems Biology and Emerging Technologies Will Catalize the Transition from Reactive Medicine to Predictive, Personalized, Preventive and Participatory (P4) Medicine. Interdisciplinary Bio Central, 1(2): 1-4.

51. Sadin É. (2018). L’Intelligence artificielle ou l’enjeu du siècle. Paris, L’Échappée, p.114.

52. Sadin (2008), op. cit., p. 259.

53. Borenstein, J., Pearson, Y. (2010). Robot caregivers: harbingers of expanded freedom for all? Ethics Information Technology 12: 277-288. DOI 10.1007//s10676-010-9236-4.

54. Broekman, J.M. (2019) Rethinking Law and Language. Cheltenham: Edward Elgar Publishing Inc., p. 201.

55. Agamben G. (2005). Profanaciones. 3ª ed. Buenos Aires: Adriana Hidalgo editora, p.97.

56. Junges, J. R. (2016) Hermenéutica como profanación de los nuevos sagrados: desafío y tarea para la bioética. Revista bioética, 24 (1): 22-28, p. 28.

58. D’Agostino, F. (1994). Bioética y derecho. Cuadernos de Bioética 1ª-2ª: 96-106.

59. Honneth, A. (1992/1997) La lucha por el reconocimiento. https://eva.fcs.edu.uy/pluginfile.php/120681/mod_resource/content/0/ PPT%20-%20Axel%20Honneth-%20La%20lucha%20por%20el%20reconocimiento%20-%20Martin%20Fleitas..pdf. Accesado Agosto 25, 2020.

60. Fraser, N., Honneth, A. (2003) . Redistribution or Recognition? A Political. Philosophical Exchange. London: Verso.

61. Garrafa, V., Lorenzo C. (2008). Imperialismo moral e ensaios clínicos multicêntricos em países periféricos. Cadernos de Saúde Pública 24 (10): 2219-2226.

62. Dawson, A., Garrard, E. (2006) In defence of moral imperialism: four equal and universal prima facie principles. Journal of Medical Ethics, 32 (4):200–204.

63. Chattopadhyay, S., De Vries, R. (2008). Bioethical concerns are global, bioethics is Western. Eubios Journal of Asian and International Bioethics 18(4): 106-109,p. 108.

64. Potter, V.R. (1971). Bioethics Bridge to the Future. Englewood Cliffs: Prentice-Hall.

65. Potter, V.R. (1962). Bridge to the Future: The Concept of Human Progress. Journal of Land Economics 38: 1-8.

66. Reich, W.T. (1994). The Word “Bioethics”: Its Birth and the Legacy of hose Who Shaped it. Kennedy Institute of Ethics Journal, 4(4): 319-335, p. 328.

67. Brody, H. (2009). The Future of Bioethics. Oxford New York: Oxford University Press,p. 178.

68. Reich, W.T. (1995). The Word “Bioethics”: The Struggle Over its Earliest Meanings. Kennedy Institute of Ethics Journal 5(1): 19-34. Potter, V. R. (1988). Global Bioethics. East Lansing: Michigan State University.

69. Potter, V.R. (1999). Fragmented Ethics and “Bridge Bioethics”. Hastings Center Report 29 (1): 38-40.

70. Whitehouse, P.J. (2003). The Rebirth of Bioethics: Extending the Original Formulations of Van Rensselaer Potter. The American Journal of Bioethics 3(4): W26-W31.

71. Pfeiffer, M.L. (ed.) (2004). Bioética ¿estrategia de dominación para América Latina? Mar del Plata: Ediciones Suárez.

72. Chattopadhyay, S., De Vries, R. (2008). Bioethical concerns are global, bioethics is Western. Eubios Journal of Asian and International Bioethics 18(4): 106-109,p. 108.